-
A Decade in Decision Making: Reviewing Trends in STAS by NICE in Different Disease Areas
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Second-Generation Colon Capsule Endoscopy for Investigation of the Colon Through Direct Visualization
Sep 9, 2025, 16:22 PM -
Robotic-Assisted Surgery Using the Da Vinci Surgical System in a Nordic Population: A Systematic Literature Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Life-Cycle Stage-Specific Prioritization of Joint Clinical Assessment PICOs: Balancing Access Potential Feasibility and Likelihood
Sep 9, 2025, 16:22 PM -
Methodological Acceptability of the Economic Analyses Assessed by the HAS in 2024
Sep 9, 2025, 16:22 PM -
Evolving Payer Preferences for Health Economic Information and Communication in the US
Sep 9, 2025, 16:22 PM -
ShinyMMD: An Open-Source Shiny Web Application for a Computer Simulation Model for Type 2 Diabetes and Its Complications
Sep 9, 2025, 16:22 PM -
Preliminary Real-World Results of a Community Pharmacy-Based Intervention in COPD: Evidence From the Chronic Diseases From A to Z Program
Sep 9, 2025, 16:22 PM -
Costs Associated With the Administration, Postinfusion Monitoring, and Management of Adverse Events (AEs) Related to Novel Drugs for Second-Line (2L+) Treatment of Small-Cell Lung Cancer (SCLC)
Sep 9, 2025, 16:22 PM -
Machine Learning Approached a 14-Item Shortened Version of the Positive and Negative Sleep Appraisal Measure (PANSAM-14)
Sep 9, 2025, 16:22 PM -
Development of an LLM-Based Computable Phenotype for Pediatric Lymphoma Subtypes Using Structured and Unstructured Electronic Medical Record Data
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of a Digital Health Intervention for Screening and Managing Hypertension at Primary Care Level in Kenya: A Microsimulation Model
Sep 9, 2025, 16:22 PM -
Surrogate Outcome Validation Within the New EU HTA Guidance Framework: Practical Considerations From an Industry Perspective Based on Experience From HTA Germany
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Adult Vaccination Programs and HTA of Vaccines Approaches in the US, UK, and France: Lessons for Poland
Sep 9, 2025, 16:22 PM -
Do We Need to Measure Social Impact of Innovative Drugs?
Sep 9, 2025, 16:22 PM -
Pragmatic Advice to Improve Assessment Schedule of Preference-Based Measures of Health to Estimate Utilities in Clinical Trials
Sep 9, 2025, 16:22 PM -
Canadian HTA Decisions (2020-2023): Comparing CDA-AMC and INESSS Recommendations on Drug Reimbursement
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Breast Cancer per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Machine Learning Applications in Treatment Pattern Analysis Using Real-World Data: A Scoping Review
Sep 9, 2025, 16:22 PM -
The Overlooked Need for Modeling Beyond Reimbursement to Support Therapy Uptake: Case Study of Botulinum Toxin for Spasticity Treatment
Sep 9, 2025, 16:22 PM